0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

DRUG THERAPY IN DEGENERATIVE DISEASE

ANDREW C. IVY, M.D.
JAMA. 1948;136(14):909-911. doi:10.1001/jama.1948.02890310001001.
Text Size: A A A
Published online

The term degeneration is used physiologically to refer to a process characterized by an impairment or perversion of the function of a tissue. It should be noted that with this definition cancer would be classified as a degeneration, and the expression "carcinomatous degeneration" of a tissue is not infrequently used.

Morphologically the degenerations form a heterogeneous group of changes in which abnormal materials collect in or between cells, with nonfatal or fatal consequences. The degenerations are believed to be due either to the metabolic disorder of cells, which arise from latent weaknesses in the constitution, or from external causative factors or a combination of both. The morphologic changes consist of "cloudy swelling," or albuminous degeneration, fatty degeneration, glycogen infiltration, amyloid degeneration, hyaline degeneration which involves collagenous connective tissue in arteriosclerosis, mucoid degeneration and the excessive deposit of urates, pigments, calcium and other substances and of the necrosis of cells.

The

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();